The "CRB2 Gene Ventriculomegaly with Cystic Kidney Disease Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the CRB2 gene, which are associated with the development of ventriculomegaly and cystic kidney disease. Ventriculomegaly is characterized by the abnormal enlargement of brain ventricles, while cystic kidney disease involves the formation of fluid-filled sacs in the kidneys, potentially leading to impaired kidney function. This genetic test is crucial for individuals with a family history or clinical symptoms suggestive of these conditions, as early detection can significantly influence management and treatment strategies. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results through advanced genetic testing technologies.
The TTPA gene plays a crucial role in the human body by encoding the alpha-tocopherol transfer protein, which is essential for the proper distribution and regulation of vitamin E, a crucial antioxidant that protects cells from damage. Mutations in the TTPA gene can lead to a rare, autosomal recessive disorder known as Vitamin E deficiency or Ataxia with Vitamin E Deficiency (AVED), which can cause neurological problems, muscle weakness, and coordination issues.
To diagnose this genetic condition, a specific genetic test is available that examines the TTPA gene for mutations. This test is crucial for individuals who have symptoms of Vitamin E deficiency or have a family history of the condition, as early detection and treatment can significantly improve the quality of life and prevent the progression of symptoms.
In the UAE, this genetic test is offered by DNA Labs UAE, a reputable laboratory known for its advanced genetic testing services. The cost of the TTPA Gene Vitamin E Familial Deficiency Genetic Test is 4400 AED. This test is performed using a sample of the patient's blood or saliva, and it involves analyzing the genetic material to identify any mutations in the TTPA gene. The results of this test can provide valuable information for the diagnosis and management of Vitamin E deficiency, allowing for personalized treatment plans that may include dietary adjustments and Vitamin E supplementation to mitigate the symptoms associated with the condition.
The SNAI2 gene plays a crucial role in the development of Waardenburg syndrome type 2D, a genetic condition characterized by varying degrees of hearing loss and pigmentation anomalies of the hair, skin, and eyes. This condition is part of a group of genetic disorders that can also affect the structure of the inner ear and lead to sensorineural hearing loss.
A genetic test specifically designed to identify mutations in the SNAI2 gene can be a critical tool for diagnosing Waardenburg syndrome type 2D. This test involves analyzing the DNA to look for specific mutations in the SNAI2 gene that are known to cause the syndrome. It is a crucial step for families seeking a definitive diagnosis, especially when planning for children or understanding the risk for future generations.
DNA Labs UAE offers this specialized genetic testing service. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the SNAI2 gene. Conducting the test in a reputable laboratory like DNA Labs UAE ensures reliability and accuracy, providing essential information for affected individuals and their families to manage the condition effectively.
The EDNRB Gene Waardenburg Syndrome-Hirschsprung Disease Genetic Test is a specialized diagnostic tool offered at DNA Labs UAE, designed to identify mutations in the EDNRB gene that are associated with Waardenburg Syndrome and Hirschsprung Disease. Waardenburg Syndrome is a group of genetic conditions that can cause hearing loss and changes in coloring (pigmentation) of the hair, skin, and eyes. Hirschsprung Disease, on the other hand, is a disorder that affects the colon and causes problems with passing stool. The EDNRB gene plays a critical role in the development of certain cells in the body, including those involved in the development of the nervous system and melanocytes, which are cells that produce pigment.
This genetic test is crucial for early diagnosis and management of individuals showing symptoms of either condition, as well as for families with a history of these diseases, providing them with vital information for future family planning. The test, which costs 4400 AED, involves analyzing the patient's DNA to look for specific mutations in the EDNRB gene that are known to cause these disorders. Conducted in the state-of-the-art facilities at DNA Labs UAE, the test adheres to the highest standards of accuracy and reliability, offering a crucial resource for affected individuals and their families seeking to understand their genetic health.
The CRPPA Gene Walker-Warburg Syndrome Genetic Test is a specialized diagnostic tool used to detect mutations in the CRPPA gene, which are associated with Walker-Warburg Syndrome (WWS). WWS is a rare genetic disorder characterized by muscle weakness, brain and eye abnormalities, and intellectual disability. This test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare providers to develop a tailored care plan for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the CRPPA gene. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for any genetic anomalies linked to WWS.
The cost of the CRPPA Gene Walker-Warburg Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate technology and expertise required to accurately identify mutations in the CRPPA gene. Early diagnosis through this test can significantly impact the management of Walker-Warburg Syndrome, providing valuable information for affected families and their healthcare teams.
The FKTN Gene Walker-Warburg Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FKTN gene, which are known to cause Walker-Warburg Syndrome (WWS). WWS is a rare genetic disorder characterized by severe brain malformations, muscle weakness, and eye abnormalities. Early and accurate diagnosis through this genetic test allows for better understanding of the condition, guiding treatment and management decisions for affected individuals.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the FKTN gene. This gene plays a crucial role in the development and maintenance of muscle and brain tissue, and mutations can lead to the symptoms associated with WWS.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the FKTN Gene Walker-Warburg Syndrome Genetic Test provides families with critical information regarding the genetic makeup and potential health challenges their loved ones may face, enabling informed healthcare decisions and support for managing the condition.
The FKRP gene (Fukutin-Related Protein gene) plays a critical role in the proper development and maintenance of muscle tissue, the brain, and the eyes. Mutations in the FKRP gene can lead to severe congenital disorders such as Walker-Warburg Syndrome (WWS) and Muscle-Eye-Brain (MEB) Disease. These conditions are characterized by muscle weakness, structural brain defects, and eye abnormalities. They are part of a group of diseases known as congenital muscular dystrophies.
To diagnose these conditions and understand the genetic basis in affected individuals, genetic testing focusing on the FKRP gene is essential. DNA Labs UAE offers a comprehensive FKRP Related Genetic Test, which is a vital tool in diagnosing conditions like Walker-Warburg Syndrome or Muscle-Eye-Brain Disease. This test is particularly crucial for families with a history of these disorders, as it can provide valuable information for disease management and genetic counseling.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. The cost of the FKRP Related Genetic Test is 4400 AED. This investment can be invaluable for affected families, offering insights into the genetic mutations responsible for these conditions and facilitating informed decisions regarding care and treatment.
The RAB3GAP1 gene is essential in the regulation of a process known as membrane trafficking within cells. Mutations in this gene are primarily associated with Warburg Micro Syndrome Type 1, a rare genetic disorder characterized by a range of symptoms including developmental delays, microcephaly, eye abnormalities, and hypotonia. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this syndrome and identify the specific genetic mutation, a genetic test targeting the RAB3GAP1 gene can be conducted. This test is crucial for families seeking a definitive diagnosis, understanding the risk of recurrence in future pregnancies, and accessing appropriate care and support for affected individuals.
DNA Labs UAE offers this specialized genetic test for Warburg Micro Syndrome Type 1. The test involves analyzing the patient's DNA to detect mutations in the RAB3GAP1 gene that are indicative of the syndrome. This process provides a precise diagnosis, enabling targeted management and care for the affected individual.
The cost of the RAB3GAP1 Gene Warburg Micro Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full analysis and reporting, offering families valuable insights into their genetic makeup and aiding in the management of the condition. It's important for interested individuals to consult with healthcare professionals and genetic counselors to understand the implications of the test results fully.
The "TWNK Gene Spinocerebellar Ataxia Infantile-Onset Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TWNK gene, which are associated with the development of spinocerebellar ataxia with infantile onset. Spinocerebellar ataxia is a progressive, degenerative genetic disorder characterized by poor coordination of hands, eyes, and speech, as well as a loss of motor control that typically begins in childhood. The TWNK gene plays a crucial role in mitochondrial DNA replication and maintenance; mutations in this gene can disrupt these processes, leading to the symptoms observed in affected individuals.
This genetic test is critical for early detection and management of the condition, enabling healthcare providers to offer targeted interventions that can improve the quality of life for affected individuals. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the TWNK gene.
The cost of the "TWNK Gene Spinocerebellar Ataxia Infantile-Onset Genetic Test" at DNA Labs UAE is 4400 AED. This investment covers the expenses related to the sophisticated techniques and equipment required for accurate genetic analysis. Early and precise diagnosis through this test can be instrumental in guiding treatment decisions, providing genetic counseling, and facilitating family planning for those carrying the gene mutation.
The "SHROOM4 Gene Stocco dos Santos X-Linked Mental Retardation Syndrome Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SHROOM4 gene, which are linked to Stocco dos Santos Syndrome. This rare genetic disorder is characterized by intellectual disability, seizures, and other neurological issues, and it predominantly affects males due to its X-linked inheritance pattern. The test involves analyzing the patient's DNA to detect any abnormalities in the SHROOM4 gene that could lead to the syndrome. With a cost of 4400 AED, this test is a critical tool for families seeking answers about this specific genetic condition, enabling early intervention and management strategies to improve the quality of life for affected individuals.
